BICO BICO Group AB (publ)

STO · SE · Healthcare · Medical Devices · bico.com

22.45SEK+4.18%Mkt Cap: 151.55M $P/E: —3d ago

BICO Group AB (publ) provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally. It operates through two segments: Life Science Solutions and Lab Automation. The …

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.60BUSDP/E 18.7

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

Key Statistics

Company

Market Cap151.55M USD

Enterprise Value151.13M USD

Revenue (TTM)143.88M USD

Gross Profit74.64M USD

Net Income (TTM)-104.16M USD

Revenue/Share21.31 SEK

Last Price22.45 SEK

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees554

CountrySE

SectorHealthcare

IndustryMedical Devices

ISINSE0013647385

Valuation

P/E (Trailing)—

P/E (Forward)-40.66

PEG—

EV/EBITDA-19.68

EV/Revenue1.05

P/S1.01

P/B0.97

EPS (TTM)-18.90

EPS (Forward)-0.53

52W Range

12.9476% of range25.42

52W High25.42 SEK

52W Low12.94 SEK

Profitability

Gross Margin52.12%

Oper. Margin-8.98%

EBITDA Margin-5.34%

Profit Margin-72.73%

ROE-62.27%

ROA-29.46%

Growth

Revenue Growth3.70%

Earnings Growth—

Cash Flow & Leverage

Operating CF6.54M USD

CapEx (TTM)2.39M USD

FCF Margin30.25%

FCF Yield28.72%

Net Debt5.65M USD

Net Debt/EBITDA-0.74

Balance Sheet

Debt/Equity0.74

Current Ratio2.42

Quick Ratio1.85

Book Value/Sh22.19 SEK

Cash/Share8.89 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 SEK

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split4:1

Split DateJan 10, 2020

Analyst Consensus

Rating—

Target (Mean)29.00 SEK

Upside (mean)+29.2%

Target Range19.00 SEK – 39.00 SEK

19.00+29.2% to mean39.00

# Analysts2

Ownership

Shares Out.69.07M

Float49.63M

Insiders28.60%

Institutions24.28%

Technical

SMA 5018.98 (+18.3%)

SMA 20018.02 (+24.6%)

Beta2.59

S&P 52W Chg13.94%

Avg Vol (30d)251.44K

Avg Vol (10d)172.78K

Technical Indicators

RSI (14)61.6

MACD0.6840

MACD Signal0.8625

MACD Hist.-0.1785

BB Upper23.16 SEK

BB Middle21.66 SEK

BB Lower20.17 SEK

BB Width13.77%

ATR (14)1.011 SEK

Vol Ratio (20d)2.16x